Clinical Trial Update: Vivax Elimination With Tafenoquine (VET) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tafenoquine for eliminating Plasmodium vivax malaria; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: Shoklo Malaria Research Unit | Conditions: Malaria, Malaria, Vivax | Phase 4 | Status: COMPLETED